CYP19A1 and endometriosis: An experiment in baboons with endometriosis, revealed that, by reducing the expression of aromatase-mRNA with Letrozole, an aromatase inhibitor, size and volume of peritoneal lesions were diminished [50], suggesting a correlation between estrogen restriction and endometriosis lesion shrinking.